Category
Category: CAR-T
Do Natural Killer Cells Hold the Key to Treating Blood Cancers?
T-Cell Therapy Firm Wins Massive €93M Series A to Treat Solid Tumors
How European Startups Have Advanced Cancer T-Cell Therapy in 2020
Meet 20 European Immuno-Oncology Companies that are Fighting Cancer
Immatics Partners GSK in Deal Worth €1B to Develop Cancer Therapies
T-Cell Discovery Could Herald Universal Cancer Immunotherapy
Adaptimmune to Take Off-The-Shelf CAR-T to Phase I with Astellas
BioNTech’s RNA-Boosted CAR T-Cell Therapy Shrinks Tumors in Mice
Cellectis’ Off-the-Shelf CAR T-Cell Therapy Shows Solid Tumor Potential
This Biotech Can Screen CAR T-Cells Using Only Light and Microfluidics
